Tower Research Capital (TRC)’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36K | Buy |
5,437
+2,498
| +85% | +$16.5K | ﹤0.01% | 3250 |
|
|
2025
Q1 | $26.9K | Sell |
2,939
-530
| -15% | -$4.85K | ﹤0.01% | 2696 |
|
|
2024
Q4 | $36.4K | Buy |
3,469
+1,786
| +106% | +$18.8K | ﹤0.01% | 2762 |
|
|
2024
Q3 | $20.1K | Buy |
+1,683
| New | +$20.1K | ﹤0.01% | 3235 |
|
|
2024
Q2 | – | Sell |
-5,051
| Closed | -$26.3K | – | 5707 |
|
|
2024
Q1 | $26.3K | Buy |
5,051
+1,438
| +40% | +$7.48K | ﹤0.01% | 2761 |
|
|
2023
Q4 | $19K | Sell |
3,613
-19,478
| -84% | -$103K | ﹤0.01% | 3679 |
|
|
2023
Q3 | $76.2K | Buy |
23,091
+16,878
| +272% | +$55.7K | ﹤0.01% | 2195 |
|
|
2023
Q2 | $18K | Sell |
6,213
-5,258
| -46% | -$15.2K | ﹤0.01% | 3460 |
|
|
2023
Q1 | $12K | Buy |
11,471
+4,590
| +67% | +$4.8K | ﹤0.01% | 4053 |
|
|
2022
Q4 | $18K | Sell |
6,881
-11,555
| -63% | -$30.2K | ﹤0.01% | 3204 |
|
|
2022
Q3 | $129K | Buy |
18,436
+4,060
| +28% | +$28.4K | ﹤0.01% | 2330 |
|
|
2022
Q2 | $98K | Buy |
14,376
+13,853
| +2,649% | +$94.4K | ﹤0.01% | 2310 |
|
|
2022
Q1 | $7K | Sell |
523
-404
| -44% | -$5.41K | ﹤0.01% | 4698 |
|
|
2021
Q4 | $13K | Buy |
927
+246
| +36% | +$3.45K | ﹤0.01% | 4153 |
|
|
2021
Q3 | $10K | Buy |
681
+153
| +29% | +$2.25K | ﹤0.01% | 4303 |
|
|
2021
Q2 | $10K | Sell |
528
-850
| -62% | -$16.1K | ﹤0.01% | 4374 |
|
|
2021
Q1 | $21K | Buy |
+1,378
| New | +$21K | ﹤0.01% | 3834 |
|